Device Medical Device

(9267) Angiosculpt Cv Rx

Payments companies reported to CMS as associated with (9267) Angiosculpt Cv Rx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6,548associated payments (2023-2025)

105clinicians with associated payments

2companies reporting

By year

2023 $6,486

2024 $62.33

Payments reported as associated with (9267) Angiosculpt Cv Rx, per program year, as reported to CMS.

Who makes it

Philips Electronics North America Corporation $6,038 associated with (9267) Angiosculpt Cv Rx (2023-2025)
Philips North America LLC $510 associated with (9267) Angiosculpt Cv Rx (2023-2025)

Specialties most often involved

Interventional Cardiology $3,097

Cardiovascular Disease $2,891

Internal Medicine $196

Adult Health (Nurse Practitioner) $61.81

Clinical Cardiac Electrophysiology $29.99

Family $28.18

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (9267) Angiosculpt Cv Rx

These are the largest totals companies reported as associated with (9267) Angiosculpt Cv Rx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Garrett Wong	Sacramento, CA	Cardiovascular Disease	$437.15
Nirav Mehta	Surprise, AZ	Interventional Cardiology	$326.24
Saifuldeen Al Qaisi	Peoria, AZ	Interventional Cardiology	$262.26
Paul Lavigne	Norfolk, VA	Interventional Cardiology	$214.83
Quang Bui	Philadelphia, PA	Cardiovascular Disease	$163.90
Stuart Beldner	Manhasset, NY	Cardiovascular Disease	$149.93
Mitchell Weinberg	Manhasset, NY	Interventional Cardiology	$149.93
Gaurav Rao	Manhasset, NY	Interventional Cardiology	$149.93
Bruce Rutkin	Manhasset, NY	Cardiovascular Disease	$149.93
Hillary Johnston-Cox	New York, NY	Cardiovascular Disease	$149.93

Prescribed (9267) Angiosculpt Cv Rx?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.